Premium
Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma
Author(s) -
Chen Y. C.,
Liaw Y. F.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13674
Subject(s) - hbsag , medicine , hepatocellular carcinoma , gastroenterology , cohort , cohort study , hepatitis b , relative risk , hepatitis b virus , confidence interval , immunology , virus